UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________________________________
SCHEDULE 13G
(Amendment No. 3)*
Under the Securities Exchange Act of 1934
Under the Securities Exchange Act of 1934
__________________________________________________
ProKidney Corp.
(Name of Issuer)
(Name of Issuer)
Class A ordinary shares, par value $0.0001 per share
(Titles of Class of Securities)
(Titles of Class of Securities)
G7S53R104
(CUSIP Number)
(CUSIP Number)
August 28, 2024
(Date of Event Which Requires Filing of this Statement)
(Date of Event Which Requires Filing of this Statement)
__________________________________________________
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐ Rule 13d-1(d)
| * |
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
|
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities
of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
1
|
NAME OF REPORTING PERSON
Averill Master Fund, Ltd.
|
|||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐ (b) ☐
|
|||
|
3
|
SEC USE ONLY
|
|||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
|
|||
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH: |
5
|
SOLE VOTING POWER
0
|
||
|
6
|
SHARED VOTING POWER
11,428,937
|
|||
|
7
|
SOLE DISPOSITIVE POWER
0
|
|||
|
8
|
SHARED DISPOSITIVE POWER
11,428,937
|
|||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,428,937
|
|||
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
|||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.1%(1)
|
|||
|
12
|
TYPE OF REPORTING PERSON
CO
|
|||
|
(1)
|
Calculated based upon 126,051,383 Issuer (as defined below) Class A ordinary shares reported to be outstanding as of August 9, 2024, as reported in the Issuer's Form 10-Q for the quarterly period ended June 30, 2024.
|
|
1
|
NAME OF REPORTING PERSON
Averill Madison Master Fund, Ltd.
|
|||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐ (b) ☐
|
|||
|
3
|
SEC USE ONLY
|
|||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
|
|||
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH: |
5
|
SOLE VOTING POWER
0
|
||
|
6
|
SHARED VOTING POWER
912,329
|
|||
|
7
|
SOLE DISPOSITIVE POWER
0
|
|||
|
8
|
SHARED DISPOSITIVE POWER
912,329
|
|||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
912,329
|
|||
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
|||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
.7%(1)
|
|||
|
12
|
TYPE OF REPORTING PERSON
CO
|
|||
|
(1)
|
Calculated based upon 126,051,383 Issuer Class A ordinary shares reported to be outstanding as of August 9, 2024, as reported in the Issuer's Form 10-Q for the quarterly period ended June 30, 2024.
|
|
1
|
NAME OF REPORTING PERSON
Suvretta Capital Management, LLC
|
|||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐ (b) ☐
|
|||||
|
3
|
SEC USE ONLY
|
|||||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||||
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH: |
5
|
SOLE VOTING POWER
0
|
||||
|
6
|
SHARED VOTING POWER
12,341,266
|
|||||
|
7
|
SOLE DISPOSITIVE POWER
0
|
|||||
|
8
|
SHARED DISPOSITIVE POWER
12,341,266
|
|||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,341,266
|
|||||
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
|||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.8%(1)
|
|||||
|
12
|
TYPE OF REPORTING PERSON
IA; OO
|
|||||
|
(1)
|
Calculated based upon 126,051,383 Issuer Class A ordinary shares reported to be outstanding as of August 9, 2024, as reported in the Issuer's Form 10-Q for the quarterly period ended June 30, 2024.
|
|||||
|
1
|
NAME OF REPORTING PERSON
Aaron Cowen
|
|||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐ (b) ☐
|
|||||
|
3
|
SEC USE ONLY
|
|||||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
|||||
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH: |
5
|
SOLE VOTING POWER
857,500
|
||||
|
6
|
SHARED VOTING POWER
12,341,266
|
|||||
|
7
|
SOLE DISPOSITIVE POWER
857,500
|
|||||
|
8
|
SHARED DISPOSITIVE POWER
12,341,266
|
|||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
13,198,766
|
|||||
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
|||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.47%
|
|||||
|
12
|
TYPE OF REPORTING PERSON
IN
|
|||||
|
(1)
|
Calculated based upon 126,051,383 Issuer Class A ordinary shares reported to be outstanding as of August 9, 2024, as reported in the Issuer's Form 10-Q for the quarterly period ended June 30, 2024.
|
|||||
| Item 1(a). |
Name of Issuer:
|
ProKidney Corp., a Cayman Islands exempted company limited by shares (the “Issuer”).
| Item 1(b). |
Address of Issuer’s Principal Executive Offices:
|
2000 Frontis Plaza Blvd., Ste 250, Winston-Salem, NC 27103
| Item 2(a). |
Name of Person Filing:
|
This Amendment No. 3 to Schedule 13G is filed by Averill Master Fund, Ltd., an exempted company incorporated and existing under the laws of the Cayman Islands (the “Averill Fund”), Averill Madison
Master Fund, Ltd., an exempted company incorporated and existing under the laws of the Cayman Islands (the “Averill Madison Fund”), Suvretta Capital Management, LLC., a Delaware limited liability company (the
“Manager”), and, Aaron Cowen, an individual (“Mr. Cowen” and, together with the Averill Fund, the Averill Madison Fund, and the Manager, the “Reporting Persons”). Mr. Cowen and the
Manager may be deemed to beneficially own the Issuer Class A ordinary shares held by the Averill Fund and the Averill Madison Fund. Mr. Cowen may be deemed to control the Manager.
| Item 2(b). |
Address of Principal Business Office or, if none, Residence:
|
The principal business address of each of the Manager and Mr. Cowen is as follows:
c/o Suvretta Capital Management, LLC
540 Madison Avenue, 7th Floor,
New York, New York 10022.
540 Madison Avenue, 7th Floor,
New York, New York 10022.
The principal business address of each of the Averill Fund and Averill Madison Fund is as follows:
c/o Maples Corporate Services Limited
P.O. Box 309
Ugland House
Grand Cayman KY1-1104
Cayman Islands
| Item 2(c). |
Citizenship:
|
See responses to Item 4 on each cover page.
| Item 2(d). |
Titles of Classes of Securities:
|
Class A ordinary shares, par value $0.0001 per share (“Issuer Class A ordinary shares”)
| Item 2(e). |
CUSIP Number:
|
The Issuer Class A ordinary shares CUSIP Number is G7S53R104.
| Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
| (a) | ☐ | Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78o). |
| (b) | ☐ | Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c). |
| (c) | ☐ | Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c). |
| (d) | ☐ | Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
| (e) | ☐ | Investment adviser in accordance with §240.13d-1(b)(1)(ii)(E). |
| (f) | ☐ | Employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F). |
| (g) | ☐ | Parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G). |
| (h) | ☐ | Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). |
| (i) | ☐ | Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). |
| (j) | ☐ | Non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). |
| (k) | ☐ | Group in accordance with §240.13d-1(b)(1)(ii)(K). |
If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ______________ .
| Item 4. |
Ownership
|
(a) Amount beneficially owned:
See responses to Item 9 on each cover page.
(b) Percent of class:
See responses to Item 11 on each cover page.
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
See responses to Item 5 on each cover page.
(ii) Shared power to vote or to direct the vote:
See responses to Item 6 on each cover page.
(iii) Sole power to dispose or to direct the disposition of:
See responses to Item 7 on each cover page.
(iv) Shared power to dispose or to direct the disposition of:
See responses to Item 8 on each cover page.
| Item 5. |
Ownership of Five Percent or Less of a Class.
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.
| Item 6. |
Ownership of More than Five Percent on Behalf of Another Person.
|
None.
| Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
|
Not Applicable.
| Item 8. |
Identification and Classification of Members of the Group.
|
Not Applicable.
| Item 9. |
Notice of Dissolution of Group.
|
Not Applicable.
| Item 10. |
Certification.
|
Each Reporting Person hereby makes the following certification:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control
of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: October 22, 2024
|
|
AVERILL MASTER FUND, LTD.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Andrew Nathanson
|
|
|
|
|
Name:
|
Andrew Nathanson
|
|
|
|
Title:
|
Authorized Signatory
|
|
|
|
|
|
|
|
AVERILL MADISON MASTER FUND, LTD.
|
||
|
|
|
|
|
|
|
By:
|
/s/ Andrew Nathanson
|
|
|
|
|
Name:
|
Andrew Nathanson
|
|
|
|
Title:
|
Authorized Signatory
|
|
|
|
|
|
|
|
SUVRETTA CAPITAL MANAGEMENT, LLC
|
||
|
|
|
|
|
|
|
By:
|
/s/ Andrew Nathanson
|
|
|
|
|
Name:
|
Andrew Nathanson
|
|
|
|
Title:
|
General Counsel and Chief Compliance Officer
|
|
|
|
|
|
|
|
/s/ Aaron Cowen
|
||
|
|
Aaron Cowen
|
||